Overview
Richard Newcomb is an Oncologist and a Hospital Medicine provider in Boston, Massachusetts. Dr. Newcomb is rated as an Advanced provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Chronic Familial Neutropenia.
His clinical research consists of co-authoring 57 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Chronic Graft Versus Host Disease (cGvHD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Corey Cutler is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Cutler is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Cutler is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Joseph Antin is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Antin is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Hepatic Venoocclusive Disease with Immunodeficiency, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Antin is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Robert Soiffer is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Soiffer is rated as an Elite provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Hepatic Venoocclusive Disease with Immunodeficiency, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft. Dr. Soiffer is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Newcomb isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Newcomb isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Newcomb isExperienced. Learn about Burkitt Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Newcomb isExperienced. Learn about Childhood Acute Myeloid Leukemia.